We are live on ! Find out more
IMNM icon

Immunome
IMNM

57 hedge funds and large institutions have $230M invested in Immunome in 2023 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 16 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,071% more capital invested

Capital invested by funds: $19.7M → $230M (+$210M)

440% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 5

430% more call options, than puts

Call options by funds: $806K | Put options by funds: $152K

167% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 6

63% more funds holding

Funds holding: 35 → 57 (+22)

30.95% more ownership

Funds ownership: 19.37% → 50.32% (+31%)

Holders
57
Holders Change
+22
Holders Change %
+62.86%
% of All Funds
0.83%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
27
Increased
16
Reduced
6
Closed
5
Calls
$806K
Puts
$152K
Net Calls
+$654K
Net Calls Change
+$484K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$32.5M
2
EC
EcoR1 Capital
California
+$32.3M
3
RG
Redmile Group
California
+$32.3M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$11.6M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$11.2M

Top Sellers

Rank Fund Capital Flow
1
AGM
Alpine Global Management
New York
-$1.44M
2
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$693K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$255K
4
SSA
Schonfeld Strategic Advisors
New York
-$152K
5
Simplex Trading
Simplex Trading
Illinois
-$102K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$41.8M +$32.5M +3,906,143 New
EC
2
EcoR1 Capital
California
$41.5M +$32.3M +3,879,415 New
RG
3
Redmile Group
California
$41.5M +$32.3M +3,879,415 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$18.6M +$11.2M +1,343,697 +339%
Janus Henderson Group
5
Janus Henderson Group
United Kingdom
$14.9M +$11.6M +1,391,471 New
APM
6
Avidity Partners Management
Texas
$14.3M +$11.1M +1,333,479 New
T. Rowe Price Associates
7
T. Rowe Price Associates
Maryland
$11.2M +$7.3M +877,592 +505%
WP
8
Woodline Partners
California
$9.87M +$7.67M +922,892 New
Point72 Asset Management
9
Point72 Asset Management
Connecticut
$7.3M +$1.14M +136,700 +25%
BlackRock
10
BlackRock
New York
$4.18M +$2.89M +348,107 +819%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$3.43M +$1.96M +236,130 +279%
Qube Research & Technologies (QRT)
12
Qube Research & Technologies (QRT)
United Kingdom
$2.18M +$1.69M +203,538 +2,035,380%
AGM
13
Alpine Global Management
New York
$2.06M -$1.44M -173,638 -47%
TD Asset Management
14
TD Asset Management
Ontario, Canada
$1.36M – – –
Renaissance Technologies
15
Renaissance Technologies
New York
$1.3M +$741K +89,100 +275%
PCM
16
Prentice Capital Management
Connecticut
$1.2M – – –
MC
17
Mayo Clinic
Minnesota
$1.16M +$902K +108,480 New
Jane Street
18
Jane Street
New York
$1.11M +$860K +103,475 New
LCM
19
Laurion Capital Management
New York
$1.1M +$856K +102,954 New
Northern Trust
20
Northern Trust
Illinois
$1.07M +$696K +83,763 +509%
Barclays
21
Barclays
United Kingdom
$882K +$686K +82,455 New
Cerity Partners
22
Cerity Partners
New York
$656K +$510K +61,346 New
Citigroup
23
Citigroup
New York
$653K +$508K +61,043 New
EL
24
EMFO LLC
Florida
$633K +$492K +59,165 New
Manulife (Manufacturers Life Insurance)
25
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$575K – – –
1
2 3

IMNM Hedge Fund Activity: Q4 2023 in Review

57 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Immunome (IMNM) for Q4 2023, worth a combined $230M — up 1,071% from $19.7M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new IMNM positions and 5 closed out — a net gain of 22 holders — while 16 added to existing stakes and 6 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $32.5M. The largest seller was Alpine Global Management, cutting an estimated $1.44M.

  • 57 institutional investors held Immunome (IMNM) as of Q4 2023, up from 35 in Q3 2023.
  • Funds reported $230M of Immunome stock for Q4 2023, up 1,071% quarter-over-quarter.
  • 27 funds opened new Immunome positions in Q4 2023 and 5 closed out, a net change of +22 holders.
  • The largest Immunome buyer in Q4 2023 was Fidelity Investments, an estimated $32.5M added.
  • The largest Immunome seller in Q4 2023 was Alpine Global Management, an estimated $1.44M sold.

Based on aggregated 13F filings for Q4 2023.